Predictive Factors for Mediastinal Nodal Failure in Locally Advanced Non-small Cell Lung Cancer (NSCLC) Patients Receiving Definitive Chemoradiation (CRT)

被引：0
|
作者：
Fernandes, A. [1 ]
Xanthopoulos, E. [1 ]
Evans, T. [1 ]
Stevenson, J. [1 ]
Alley, E. [1 ]
Aggarwal, C. [1 ]
Langer, C. [1 ]
Simone, C. [1 ]
Rengan, R. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S232 / S233
页数：2
相关论文
共 50 条
  • [31] Patterns of Recurrence in Patients With Locally Advanced Non-Small Cell Lung Cancer (LANSCLC) Treated With Concurrent Chemoradiation (CRT) Followed by Surgery
    Bhooshan, N.
    Vyfhuis, M.
    Feliciano, J.
    Bentzen, S. M.
    Nichols, E. M.
    Edelman, M. J.
    Burrows, W.
    Suntharalingam, M.
    Carr, S.
    Friedberg, J.
    Badiyan, S. N.
    Feigenberg, S. J.
    Mohindra, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E452 - E452
  • [32] Predictive factors for symptomatic radiation pneumonitis in 293 consecutively treated non-small cell lung cancer (NSCLC) patients receiving definitive radiation therapy
    Orisamolu, A.
    Xanthopoulos, E.
    Fernandes, A.
    Christodouleas, J. P.
    Apisarnthanarax, S.
    Mitra, N.
    Wan, F.
    Langer, C. J.
    Evans, T. L.
    Stevenson, J.
    Sterman, D.
    Vachani, A.
    Haas, A. R.
    Rengan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Predicting Failure Patterns in Patients with Inoperable Local Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
    Zhu, X.
    Li, X.
    Fu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S631 - S631
  • [34] Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
    Guo, Matthew Z.
    Murray, Joseph C.
    Ghanem, Paola
    Voong, K. Ranh
    Hales, Russell K.
    Ettinger, David
    Lam, Vincent K.
    Hann, Christine L.
    Forde, Patrick M.
    Brahmer, Julie R.
    Levy, Benjamin P.
    Feliciano, Josephine L.
    Marrone, Kristen A.
    CLINICAL LUNG CANCER, 2022, 23 (07) : 620 - 629
  • [35] Is PET/CT Response of Prognostic Value in Intensified Definitive Chemoradiation for Locally Advanced Non-small Cell Lung Cancer?
    Poettgen, C.
    Eberhardt, W. E.
    Gauler, T.
    Krbek, T.
    Berkovic, K.
    Abu Jawad, J.
    Welter, S.
    Teschler, H.
    Stamatis, G.
    Stuschke, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S449 - S449
  • [36] Single institution toxicity of definitive chemoradiation and maintenance durvalumab in locally advanced non-small cell lung cancer.
    Prodduturvar, Pranitha
    Leventakos, Konstantinos
    Potter, Ashley
    Gao, Robert W.
    Dimou, Anastasios
    Marks, Randolph
    Garces, Yolanda I.
    Olivier, Kenneth R.
    Molina, Julian R.
    Merrell, Kenneth
    Mansfield, Aaron Scott
    Adjei, Alex A.
    Schwecke, Anna
    Hocum, Craig
    Moffett, Jenesse Nicole
    Park, Sean Sunghun
    Owen, Dawn
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [38] Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?
    Scartozzi, Mario
    Mazzanti, Paola
    Giampieri, Riccardo
    Berardi, Rossana
    Galizia, Eva
    Gasparini, Stefano
    Zuccatosta, Lina
    Cascinu, Stefano
    LUNG CANCER, 2010, 68 (03) : 433 - 437
  • [39] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [40] Surgical Salvation After Full-Dose Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ahn, S.
    Na, K.
    Kim, Y.
    Kim, K.
    Oh, I.
    Song, S.
    Chung, W.
    Nam, T.
    Song, J.
    Yoon, M.
    Jeong, J.
    Kim, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S619 - S619
12345